- Home
- ENR vs BEAM Comparison
ENR vs BEAM Comparison
Compare ENR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENR
- BEAM
- Stock Information
- Founded
- ENR 2015
- BEAM 2017
- Country
- ENR United States
- BEAM United States
- Employees
- ENR N/A
- BEAM N/A
- Industry
- ENR Industrial Machinery/Components
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENR Miscellaneous
- BEAM Health Care
- Exchange
- ENR Nasdaq
- BEAM Nasdaq
- Market Cap
- ENR 2.5B
- BEAM 2.3B
- IPO Year
- ENR N/A
- BEAM 2020
- Fundamental
- Price
- ENR $29.65
- BEAM $25.06
- Analyst Decision
- ENR Hold
- BEAM Buy
- Analyst Count
- ENR 8
- BEAM 11
- Target Price
- ENR $38.38
- BEAM $52.00
- AVG Volume (30 Days)
- ENR 635.4K
- BEAM 2.2M
- Earning Date
- ENR 05-06-2025
- BEAM 05-06-2025
- Dividend Yield
- ENR 4.07%
- BEAM N/A
- EPS Growth
- ENR N/A
- BEAM N/A
- EPS
- ENR 0.79
- BEAM N/A
- Revenue
- ENR $2,902,100,000.00
- BEAM $63,518,000.00
- Revenue This Year
- ENR $2.42
- BEAM N/A
- Revenue Next Year
- ENR $1.32
- BEAM $6.32
- P/E Ratio
- ENR $37.26
- BEAM N/A
- Revenue Growth
- ENR N/A
- BEAM N/A
- 52 Week Low
- ENR $26.92
- BEAM $20.84
- 52 Week High
- ENR $39.52
- BEAM $37.42
- Technical
- Relative Strength Index (RSI)
- ENR 34.78
- BEAM 42.43
- Support Level
- ENR $29.58
- BEAM $24.03
- Resistance Level
- ENR $31.78
- BEAM $28.49
- Average True Range (ATR)
- ENR 0.74
- BEAM 2.62
- MACD
- ENR 0.05
- BEAM -0.36
- Stochastic Oscillator
- ENR 17.12
- BEAM 15.75
About ENR Energizer Holdings Inc.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.